- Home
- ACHV vs REFI Comparison
ACHV vs REFI Comparison
Compare ACHV & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHV | REFI |
|---|---|---|
| Founded | N/A | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.0M | 255.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACHV | REFI |
|---|---|---|
| Price | $5.79 | $12.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $15.50 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 660.3K | 163.4K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 16.41% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | ★ $54,287,847.00 |
| Revenue This Year | N/A | $13.78 |
| Revenue Next Year | N/A | $4.07 |
| P/E Ratio | ★ N/A | $7.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.84 | $11.85 |
| 52 Week High | $6.03 | $16.27 |
Technical Indicators
Market Signals| Indicator | ACHV | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 69.73 | 48.81 |
| Support Level | $5.30 | $12.25 |
| Resistance Level | $5.72 | $12.83 |
| Average True Range (ATR) | 0.34 | 0.28 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 86.38 | 50.38 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.